Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 37 filings·Updated 11 Aug 2026
Showing 10 of 37 filings.
11 Aug 20261 filing
Company UpdateNewspaper Publication

Newspaper Advertisements published for Standalone Unaudited Financial Results for the quarter ended June 30, 2026

Filed 14:34View Source
10 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Lotus Eye Hospital approves standalone unaudited Q1 FY2026 results for quarter ended June 30, 2026

Financial results and governance

  • Standalone unaudited results for quarter ended June 30, 2026 approved; Limited Review Report issued.
  • Board notes no subsidiaries/associates; consolidation not applicable.
  • Single segment: Eye Care related sales and services.
  • Audit committee reviewed; board approved the results on 10 August 2026.
  • Statutory auditors conducted a limited review; no audit opinion issued.
  • Notes: Exceptional item relates to profit/loss on sale of PPE.
Filed 18:38View Source
6 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dematerialisation processing completed; securities listed; ownership updated

Dematerialisation status

  • Dematerialisation requests processed and confirmed to depositories; listed on stock exchanges.
  • Certificates received for dematerialisation mutilated and cancelled after verification.
  • Depository's name substituted as registered owner within prescribed timelines.
Filed 12:00View Source
27 May 20261 filing
Company UpdateNewspaper Publication

Newspaper Advertisements published for Standalone Audited Financial Results approved by the Board of Directors at its meeting held on May 26, 2026

Filed 10:55View Source
18 Apr 20261 filing
Company UpdateGeneral

Please refer the attachment

Filed 13:12View Source
7 Apr 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

Filed 12:08View Source
26 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Closure of Trading Window

Filed 11:20View Source
17 Mar 20261 filing
Board MeetingOutcome of Board Meeting

Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Outcome for Outcome Of The Board Meeting

Board Decision on Delisting

  • Board decided not to proceed with voluntary delisting from NSE
  • Company will remain listed on both BSE and NSE
  • Decision based on market conditions, liquidity, and investor convenience
Filed 17:13View Source
12 Mar 20261 filing
Board Meeting

Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Intimation for To Consider The Proposal For Voluntary Delisting Of The Company''s Equity Shares From NSE.

🗓️ Meeting Details

  • Board meeting scheduled for Tuesday, March 17, 2026.

📍 Key Agenda Items

  • Proposal for voluntary delisting from National Stock Exchange of India Limited (NSE).
  • Company to remain listed on BSE Limited after NSE delisting.
Filed 18:24View Source
4 Mar 20261 filing
Company UpdateAward of Order / Receipt of Order

Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

Regulatory Compliance and Penalties ️

  • BSE and NSE imposed fines of Rs.2,17,120 each inclusive of GST for non-compliance with SEBI LODR Regulation 17(1A).
  • The non-compliance related to the quarter ended December 31, 2025, and was rectified by shareholder approval via Postal Ballot on January 17, 2026.
  • The company paid all fines up to the quarter ended September 30, 2025, prior to this levy.
  • The Board reviewed the non-compliance and fine on February 11, 2026.
  • The company confirmed no material financial or operational impact from the fines.
  • No related party or promoter group involvement was indicated in the filing.
Filed 21:50View Source
Showing 10 of 37 filings